Nutritional Growth Solutions Ltd. (NGS) AI Stock Analysis

• Market Cap: AU$6.66M
• Dividend Yield: N/A
• Average Volume (3M): 283.41K
• Price to Earnings (P/E): ―
• Beta (1Y): -8.34
• Revenue Growth: -21.84%
• EPS Growth: 79.99%
• Country: AU
• Employees: N/A
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): -1.57
• Shares Outstanding: 333,093,200
• 10 Day Avg. Volume: 24,410
• 30 Day Avg. Volume: 283,411
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.10
• Price to Sales (P/S): 0.01
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: AU$0.02 ▼(-5.00% Downside)
• Action: Reiterated Date: 03/06/26
• Date: Action: Reiterated 03/06/26

The score is primarily constrained by weak financial performance (shrinking revenue, compressed margins, sustained losses, and ongoing cash burn with elevated funding risk). Technicals are neutral with limited trend strength, and valuation is pressured by a negative P/E and no provided dividend yield.

Positive Factors

Balance sheet improvement - equity recovery

Restoring positive equity provides a tangible solvency improvement versus prior years. A positive equity cushion (albeit small) reduces immediate insolvency risk, improves lender and supplier confidence, and modestly increases capacity to absorb losses or access debt/equity financing over the medium term.

Narrowing losses and improving cash flow trend

Reduced absolute losses and a meaningful improvement in operating cash outflow indicate management progress on cost control or business stabilization. If sustained, this trend lowers near-term funding needs, increases runway, and supports a path toward break-even and structural cash-generation.

Expanded asset base

A larger asset base can support operational scale, inventory management, and potential collateral for financing. Maintaining or leveraging these assets helps underpin working-capital operations and provides optionality for restructuring, partnerships, or targeted investment to rebuild revenue over coming quarters.

Negative Factors

Material revenue decline

Sustained, large revenue contraction erodes scale economics and market position. Lower top-line reduces fixed-cost absorption, weakens supplier/retailer bargaining power, and makes margin recovery harder. Persisting shrinkage materially increases dependence on external funding to sustain operations.

Sharp gross margin compression

A halving of gross margin signals structural pricing, input-cost, or mix pressures that impair sustainable profitability. Lower gross margins limit the company’s ability to cover SG&A and fixed costs, reducing operating leverage and making future profitability contingent on either cost reengineering or material revenue mix improvement.

Persistent cash burn and higher leverage

Ongoing negative operating cash flow combined with rising debt and a thin equity cushion elevates funding risk. Continued cash burn forces reliance on new capital or restructuring, risks dilution or restrictive covenants, and constrains investment, hampering recovery prospects over the medium term.

Nutritional Growth Solutions Ltd. Business Overview & Revenue Model

Company Description

Nutritional Growth Solutions Ltd. develops, produces, and sells pediatric protein supplements in the United States and internationally. It offers its products under the Horlicks, Healthy Height, and Pro Up brand names. The company was formerly known as N. G. Solutions Ltd. and changed its name to Nutritional Growth Solutions Ltd. in June 2020. The company was incorporated in 2013 and is based in Tel Aviv, Israel.

How the Company Makes Money

Nutritional Growth Solutions Ltd. generates revenue primarily through the sale of its nutritional products, which are distributed via multiple channels, including direct-to-consumer online sales, partnerships with healthcare providers, and retail distribution. The company leverages scientific research and clinical studies to develop its product line, which enhances its credibility and marketability. NGS also benefits from strategic partnerships and distribution agreements with major retailers and online platforms, expanding its market reach. The company's revenue streams are bolstered by its ability to cater to a niche market focused on child nutrition, coupled with ongoing marketing efforts to raise awareness about the importance of children's health and nutritional needs.

Nutritional Growth Solutions Ltd. Financial Statement Overview

Summary

Income statement and cash flow are very weak: revenue declined materially, gross margin compressed sharply, net losses remain larger than revenue, and operating cash flow is persistently negative despite some improvement in 2025. Balance sheet equity returned to positive, but leverage increased and the equity cushion remains thin.

Income Statement

Revenue has declined materially over time (down from 3.06M in 2023 to 1.68M in 2025), and profitability remains deeply negative. Gross margin compressed to ~15.7% in 2025 from ~32.7% in 2024, while net losses stayed roughly the size of (or larger than) revenue (2025 net margin about -105%). The main positive is that losses narrowed in absolute dollars in 2025 versus 2024, but the overall trajectory still reflects weak scale and limited operating leverage.

Balance Sheet

Leverage increased meaningfully in 2025, with debt rising to ~504K and debt-to-equity at ~2.1x, indicating a more debt-dependent capital structure. A key improvement is that equity moved back to positive in 2025 (~240K) after being negative in 2023–2024, but returns remain very weak given ongoing losses (2025 return on equity is sharply negative). Assets expanded to ~1.79M in 2025, yet the balance sheet still looks fragile due to limited equity cushion and continued earnings pressure.

Cash Flow

Cash generation is consistently negative, with operating cash flow outflows every year and still substantial in 2025 (~-1.25M). 2025 improved versus 2024 (~-1.93M), but cash burn remains high relative to the company’s revenue base, keeping funding risk elevated. Reported free cash flow is inconsistent across years (including 2025 shown as 0), but the broader pattern is persistent cash consumption rather than self-funded operations.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.68M	2.48M	3.06M	2.95M	3.04M
Gross Profit	263.89K	811.00K	842.00K	1.44M	1.36M
EBITDA	-1.66M	-2.45M	-3.01M	-4.32M	-4.71M
Net Income	-1.77M	-2.54M	-2.89M	-4.25M	-4.78M
Balance Sheet
Total Assets	1.79M	709.00K	936.00K	3.03M	3.44M
Cash, Cash Equivalents and Short-Term Investments	517.35K	31.00K	172.00K	1.52M	3.00M
Total Debt	504.34K	162.00K	362.00K	37.00K	73.00K
Total Liabilities	1.55M	1.37M	1.11M	954.00K	626.97K
Stockholders Equity	240.16K	-658.00K	-177.00K	2.08M	2.81M
Cash Flow
Free Cash Flow	0.00	-1.93M	-2.35M	-6.98M	-3.74M
Operating Cash Flow	-1.25M	-1.93M	-2.35M	-6.97M	-3.69M
Investing Cash Flow	0.00	0.00	0.00	-4.00K	-63.06K
Financing Cash Flow	1.77M	1.78M	998.00K	2.21M	3.42M

Nutritional Growth Solutions Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
NGS	42 Neutral	AU$6.66M	-0.01	―	―	-21.84%	79.99%
EVE	41 Neutral	AU$5.70M	-1.62	-60.84%	―	-18.70%	20.83%
NUC	41 Neutral	AU$18.82M	-2.06	-29.43%	―	102.21%	69.47%
HCT	39 Underperform	AU$22.81M	-33.08	―	―	6.76%	―
TFL	38 Underperform	AU$1.94M	-0.12	-115.03%	―	24.70%	-312.00%

Nutritional Growth Solutions Ltd. Corporate Events

Nutritional Growth Solutions Names New ASX Liaison to Bolster Governance

Nutritional Growth Solutions has appointed Adam Gallagher as its new local agent and the responsible person for communications with the ASX, effective immediately. Gallagher, an experienced company secretary and governance professional who supports multiple ASX-listed companies through his firm Applied Corporate Governance Partners, will now oversee all formal exchanges between the company and the exchange, signaling a tightening of compliance and corporate governance structures.

The company, which specializes in clinically tested nutritional supplements for children aged three to twelve, continues to differentiate itself within the fast-growing nutritional supplements market. By strengthening its ASX liaison function and governance oversight while maintaining its focus on pediatric nutrition, Nutritional Growth Solutions aims to support its capital markets presence and reassure investors of its operational discipline and regulatory responsiveness.

The most recent analyst rating on (AU:NGS) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Nutritional Growth Solutions Ltd. stock, see the AU:NGS Stock Forecast page.

Nutritional Growth Solutions Cuts Costs, Raises Capital and Resets Leadership to Drive Scalable Growth

Nutritional Growth Solutions reported Q4 FY25 revenue of US$362,000, slightly lower than the prior quarter, but significantly improved operating cash outflows, with net cash used in operations reduced 59% to US$181,000 on the back of cuts to staff, administration, and corporate costs. A refreshed leadership team, including the appointment of Andrew Grover as interim CEO and chair and Manik Pujara as executive director, has identified around US$600,000 in annual structural cost savings and is shifting the company to a shared services operating model to enhance scalability and support potential value-accretive M&A without raising the fixed cost base. The company has secured firm commitments for a A$2.0 million equity placement and an interim interest-free loan facility of up to A$250,000 to bolster working capital, expects inventory levels to normalise by mid-February, and plans to restart marketing campaigns, positioning it to pursue near-term sales growth while maintaining tighter capital and cost discipline.

The most recent analyst rating on (AU:NGS) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Nutritional Growth Solutions Ltd. stock, see the AU:NGS Stock Forecast page.

Nutritional Growth Solutions Options Lapse, Trimming Potential Future Dilution

Nutritional Growth Solutions Ltd has notified the market that 557,145 options (NGSAJ), exercisable at A$0.10 and due to expire on 31 December 2025, have lapsed after the conditions for their conversion were not, or could not be, satisfied. The cessation of these options slightly reduces the company’s potential future share dilution and clarifies its capital structure for investors, with no new capital raised from the lapsed securities.

The most recent analyst rating on (AU:NGS) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Nutritional Growth Solutions Ltd. stock, see the AU:NGS Stock Forecast page.

Nutritional Growth Solutions Raises Capital via Placement to Professional Investors

Nutritional Growth Solutions Ltd. has issued 100 million fully paid ordinary shares at $0.02 each to professional and sophisticated investors, following shareholder approval at a general meeting on 23 December 2025. The company confirmed the shares were issued without a prospectus under applicable Corporations Act provisions, stated that it remains compliant with its continuous disclosure and reporting obligations, and affirmed there is no excluded information, signalling a routine capital-raising step designed to support its operations while maintaining regulatory transparency for investors.

Nutritional Growth Solutions Seeks ASX Quotation for 100 Million New Shares

Nutritional Growth Solutions Ltd has applied to the ASX for quotation of 100 million new fully paid ordinary shares, with an issue date of 24 December 2025, under an Appendix 2A application following a previously announced Appendix 3B transaction. The substantial share issuance is expected to expand the company’s equity base and may support future capital needs, potentially influencing its market liquidity, ownership structure and capacity to fund strategic initiatives.

Nutritional Growth Solutions Director Stephen Turner Steps Down but Retains Stake

Nutritional Growth Solutions Ltd has announced the resignation of director Stephen Turner, who ceased to be a board member on 24 December 2025. In his final director’s interest notice to the ASX, the company disclosed that Turner retains significant holdings in the company, including ordinary shares and options, indicating that while he is stepping down from a governance role he remains financially exposed to the company’s performance, a point of note for investors monitoring board changes and ownership structure.

Nutritional Growth Solutions Appoints Interim CEO as Stephen Turner Steps Down

Nutritional Growth Solutions has announced that CEO and Managing Director Stephen J. Turner will step down from his role, effective 30 January 2026, under a mutual agreement with the board. Turner will remain with the company until his departure date to ensure an orderly handover of information, systems and operational responsibilities, with all his remuneration and entitlements settled in full. Non-executive director Andrew Grover, an experienced executive and investor known for business turnarounds and growth, will assume the role of interim CEO without additional remuneration while the board searches for a permanent chief executive, signaling a leadership transition aimed at maintaining operational continuity and potentially sharpening the company’s strategic and commercial focus.

Nutritional Growth Solutions Issues New Shares to Dicofarm Under Cleansing Notice

Nutritional Growth Solutions has issued 12,965,673 fully paid ordinary shares at $0.021760 each to Dicofarm S.p.A., following shareholder approval at a general meeting on 23 December 2025. The new shares were issued without a disclosure document under the Corporations Act’s fundraising provisions, with the company confirming it is compliant with financial reporting and continuous disclosure obligations and stating there is no excluded information, signaling routine capital management while maintaining regulatory transparency for investors.

Nutritional Growth Solutions Seeks ASX Quotation for Nearly 13m New Shares

Nutritional Growth Solutions Ltd. has applied to the ASX for quotation of 12,965,673 new fully paid ordinary shares, scheduled to be issued on 24 December 2025. The new securities, which follow a previously announced transaction, will expand the company’s quoted share capital and may influence its market liquidity and investor base as it continues executing its capital and growth plans.

Nutritional Growth Solutions Director Increases Equity Stake Following Shareholder Approval

Nutritional Growth Solutions Ltd has announced a change in director Stephen Turner’s interests in the company’s securities, following shareholder approval at an extraordinary general meeting held on 23 December 2025. Turner acquired 2,107,692 new ordinary shares at $0.03 per share and transferred 1,250,000 existing shares to Citicorp Nominees Pty Limited as custodian for administrative purposes, a move that did not alter his beneficial ownership. After the change, Turner holds a combination of direct and indirect interests in ordinary shares and previously issued options, reflecting an increased equity stake that further aligns his interests with those of shareholders.

Nutritional Growth Solutions Issues Nearly 6 Million New Shares Under Cleansing Notice

Nutritional Growth Solutions Ltd. has issued 5,959,775 fully paid ordinary shares without a prospectus under Australian disclosure rules, and has confirmed its ongoing compliance with key financial reporting and continuous disclosure obligations under the Corporations Act. The cleansing notice indicates there is no excluded information withheld from the market, supporting transparency for investors as the company adjusts its capital structure and potentially broadens its shareholder base.

Nutritional Growth Solutions to Issue 25 Million Unquoted Options

Nutritional Growth Solutions Ltd has notified the ASX that it will issue 25 million unquoted options exercisable at A$0.025 and expiring on 23 December 2028, with the issue scheduled for 29 December 2025. The options form part of a previously announced transaction and will not be quoted on the ASX, indicating a capital structure move that may affect existing holders through potential future dilution while providing additional incentive or funding flexibility for the company’s stakeholders involved in that transaction.

Nutritional Growth Solutions Shareholders Back All Resolutions at General Meeting

Nutritional Growth Solutions Ltd. has announced that all resolutions put to shareholders at its 23 December 2025 General Meeting were passed by poll. The approvals cover ratification of prior share issues, the issuance of shares to key individuals and partners, the establishment of an incentive plan, and the issuance of securities tied to a recent placement and lead manager options, collectively reinforcing the company’s capital structure and incentives framework as it pursues growth in the pediatric nutritional supplements market.